BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4479803)

  • 1. [The elimination of the antibiotic cephacetrile in patients with impaired renal function].
    Spring P; Räber J; Reber H; Dettli L
    Arzneimittelforschung; 1974 Sep; 24(9b):1462-6. PubMed ID: 4479803
    [No Abstract]   [Full Text] [Related]  

  • 2. [The course of serum levels of a new cephalosporin, cephacetrile, as a function of renal elimination capacity].
    Brogard JM; Ruscher H; Frankhauser J; Kuntzmann F; Lavillaureix J
    Arzneimittelforschung; 1974 Sep; 24(9b):1491-7. PubMed ID: 4479810
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function.
    Westenfelder SR; Naber KG; Madsen PO
    Arzneimittelforschung; 1974 Sep; 24(9b):1481-5. PubMed ID: 4479808
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibacterial activity, pharmacokinetics and clinical use of a new cephalosporin antibiotic cephacetrile].
    Brogard JM; Kuntzmann F; Lavillaureix J
    Arzneimittelforschung; 1974 Sep; 24(9b):1528-33. PubMed ID: 4479819
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum half-lives and elimination rates of a new semi-synthetic cephalosporin, cephacetrile, in nephrectomized patients and in patients with impaired or normal renal function.
    Reutter F; Maurice NP
    Arzneimittelforschung; 1974 Sep; 24(9b):1466-8. PubMed ID: 4479804
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of renal insufficiency and hemodialysis on cephacetrile pharmacokinetics].
    Nissenson AR; Levin NW; Parker RH
    Arzneimittelforschung; 1974 Sep; 24(9b):1470-3. PubMed ID: 4479806
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of renal failure and hemodialysis on cephacetrile pharmacokinetics.
    Nissenson AR; Levin NW; Parker RH
    Clin Pharmacol Ther; 1972; 13(6):887-94. PubMed ID: 5081601
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal handling and lymph concentration of two cephalosporin analogues, cephacetrile and cephaloridine. An experimental study in dogs.
    Naber KG; Madsen PO
    Arzneimittelforschung; 1974 Sep; 24(9b):1485-91. PubMed ID: 4479809
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function.
    Westenfelder SR; Naber KG; Madsen PO
    Infection; 1973; 1(3):157-62. PubMed ID: 4597098
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum levels of a new cephalosporin, cephacetrile, as a function of renal excretion capacity].
    Brogard JM; Ruscher H; Frankhauser J; Kuntzmann F; Lavillaureix J
    Pathol Biol (Paris); 1973 Jun; 21(6):671-9. PubMed ID: 4581199
    [No Abstract]   [Full Text] [Related]  

  • 11. [Elimination of the antibiotic cephacetril in patients with impaired renal function].
    Spring P; Räber J; Reber H; Dettli L
    Schweiz Med Wochenschr; 1973 May; 103(21):783-8. PubMed ID: 4704362
    [No Abstract]   [Full Text] [Related]  

  • 12. Multicentre trial with cephacetrile in the treatment of severe infections.
    Corrêa Lima MB; Louro E; Netto AR; Borges da Cunha A; Polisuk J; Mangabeira Albernaz PL; Bethlem N; da Rosa Santos O; Freire de Sequeira O; Aguinaga S; Coelho Gomes S
    Arzneimittelforschung; 1974 Sep; 24(9b):1515-23. PubMed ID: 4479817
    [No Abstract]   [Full Text] [Related]  

  • 13. A preliminary communication on the use of cephacetrile as monotherapy in the treatment of purulent meningitis.
    Corrêa Lima MB; Carvalho Neto E; Gorinstein J; Casz I
    Arzneimittelforschung; 1974 Sep; 24(9b):1512-5. PubMed ID: 4479816
    [No Abstract]   [Full Text] [Related]  

  • 14. Contribution to the pharmacokinetics of a new cephalosporin derivative.
    Dvorácek K; Modr Z; Schmidt O; Necásková A
    Arzneimittelforschung; 1974 Sep; 24(9b):1468-70. PubMed ID: 4479805
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal effects of cephacetrile in man, in healthy and diseased subjects.
    Mioli V; Vangelista 'A; Albertazzi A; Bortolotti GC; Bonomini V
    Arzneimittelforschung; 1974 Sep; 24(9b):1504-5. PubMed ID: 4479812
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary studies of serum levels and the excretion of a new cephalosporin derivative, the sodium salt of 7-cyanoacetamido-cephalosporanic acid (CIBA 36,278A-Ba) in normal human subjects and rabbits.
    Luscombe DK; Nicholls PJ; Owens DR; Russell AD
    Br J Pharmacol; 1972 Nov; 46(3):552P-553P. PubMed ID: 4656632
    [No Abstract]   [Full Text] [Related]  

  • 17. Amantadine hydrochloride pharmacokinetics in patients with impaired renal function.
    Wu MJ; Ing TS; Soung LS; Daugirdas JT; Hano JE; Gandhi VC
    Clin Nephrol; 1982 Jan; 17(1):19-23. PubMed ID: 7035042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of nitrendipine in patients with renal failure: comparison to normal subjects.
    Aronoff GR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S974-6. PubMed ID: 6085387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
    Leroy A; Canonne MA; Fillastre JP; Humbert G
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):878-89. PubMed ID: 4214662
    [No Abstract]   [Full Text] [Related]  

  • 20. [Doxycycline (Vibramycin) in renal failure].
    Stenbaek O; Myhre E; Berdal BP
    Tidsskr Nor Laegeforen; 1974 Dec; 94(34-36):2388-9. PubMed ID: 4614492
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.